1 ml of the product contains:

• active substance: chloramphenicol - 2.5 mg;
• excipients: boric acid, water for injection

Eye drops 0.25%, 0.5%, 10 ml.

Medications for eye diseases. Antimicrobials. Antibiotics. Chloramphenicol.

ATC code S01АА01

Conjunctivitis, keratitis, blepharitis caused by microorganisms sensitive to the product.

• hypersensitivity to the components of the product;
• individual intolerance;
• skin diseases (psoriasis, eczema, fungal lesions);
• acute intermittent porphyria;
• viral and fungal eye diseases;
• myelosuppression after previous use of chloramphenicol;
• Acquired or hereditary blood dyscrasias, including aplastic anemia;
• glucose-6-phosphate dehydrogenase deficiency;
• pregnancy and lactation period;
• children under 1 year of age;
• hepatic and/or renal failure.

The product is instilled into the conjunctival sac using a pipette:

• for children of 3 to 8 years of age - 1 drop 3-4 times a day in both eyes;
• for children over 8 years of age and adults - 1-2 drops 3-4 times a day in both eyes.
  The duration of treatment is determined by the attending physician individually for each patient.

Make sure that the tip of the dropper bottle does not come into contact with other objects or surfaces when instilling. Close the dropper bottle tightly with the cap after instillation!

In the first seconds after instillation, there may be a burning sensation that passes quickly.

Immune system, skin and subcutaneous tissue disorders: allergic reactions, including rash, angioedema, urticaria, pruritus, skin hyperemia, fever, vesicular and papular dermatitis, anaphylactic shock.

Nervous system disorders: neuritis of the optic and peripheral nerves, possible headache, dizziness.

General disorders and administration site conditions: local reactions including eyelid swelling, itching, dermatitis, eye irritation, and lacrimation are possible.

Rare: aplastic anemia.

Symptoms: increased side effects. Increased doses of levomycetin may lead to a temporary decrease in visual acuity.

Treatment: withdrawal of the product, rinse the eyes with running water. Symptomatic treatment.

Contraindicated.

Approved for children over 1 year of age.

Chloramphenicol can be systemically absorbed from mucous membranes, causing systemic effects. The possibility of bone marrow hypoplasia, including aplastic anemia with fatal outcome after topical application of chloramphenicol, has been described. Such cases are rare and here it is necessary to assess the risk and feasibility of chloramphenicol. In both short-term and long-term use of chloramphenicol eye drops, it may be advisable to monitor the blood picture before therapy and at appropriate intervals, for possible abnormalities in the hematopoietic system. In severe infections, local application of chloramphenicol is supplemented by appropriate systemic therapy.

Prolonged use of chloramphenicol eye drops should be avoided because it can lead to sensitization and emergence of resistant microorganisms. If any new infectious factor appears, treatment with this antibiotic must be discontinued and appropriate measures must be taken. Chloramphenicol should be relegated to the category of reserve drugs for the treatment of sensitive microorganisms.

Chloramphenicol is not sufficiently active against Pseudomonas aeruginosa and Enterobacteriaceae Serratia marcescens.

Do not use the product for more than 5 days without consulting your doctor.

Physician consultation is required if there is no improvement in health after 2 days of use or if symptoms worsen, regardless of the timing of use.

The patient should see a doctor if the following symptoms are found:

• visual impairment;
• severe pain in the eyes;
• photophobia;
• eye inflammation associated with a rash on the scalp or face;
• blurred vision;
• If the pupil looks unusual;
• suspicion of a foreign body in the eye.

Before using eye drops, the patient also needs to consult a doctor in the following cases:

• with recent conjunctivitis;
• glaucoma;
• dry eye syndrome;
• surgical or laser eye surgery within the last 6 months;
• eye injuries of any origin;
• current use of other eye drops or eye ointments;
• using contact lenses of any type to avoid damaging the lens.

The product should not be prescribed for prophylactic purposes. Unreasonable prescription of the product and its use in mild forms of infectious diseases, especially in pediatric practice, is not allowed.

During treatment, systematic monitoring of peripheral blood counts is necessary.

Caution is used in patients who have previously been treated with cytostatic drugs or radiation therapy.

To avoid contamination of the solution, keep the bottle tightly closed and avoid contact of the pipette tip with any surface.

Effects on ability to drive and use machines

You should refrain from driving motor vehicles or operating other machinery for 1 hour after taking the product (until the vision clears up).

5 ml, 10 ml and 15 ml of the product in plastic dropper bottles, sealed with tamper-proof caps, or in plastic dropper bottles, sealed with caps.
Each bottle has a label made of label paper.
One bottle is with instruction for use in the state and Russian language are placed in a carton pack.

In a place protected from light, at a temperature below 25^оС.

Keep out of the reach of children.

2 years.

After opening the bottle, the period of using the product is 15 days.

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan, tel.: (727) 253-03-88.

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan.

Name, address, contact information of the organization accepting claims (proposals) against quality of products from consumers in the territory of the Republic of Kazakhstan, which is responsible for post-authorization safety surveillance of the medicine:

"DOSFARM" LLP, 3 Chaplygin street, Almaty city, 050034, Kazakhstan,

Tel./Fax: (727) 253-07-07, 253-03-88, e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.